Talazoparib: First Global Approval

Hoy, SM

Hoy, SM (reprint author), Springer, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2018; 78 (18): 1939

Abstract

Talazoparib (TALZENNA) is an oral inhibitor of the polyadenosine 5-diphosphoribose polymerase (PARP) enzymes, which play a critical role in repairing ......

Full Text Link